Industry News: Why Pharma Whistleblowers Are A Harried Lot
82% of whistleblowers in NEJM study were subjected to pressures by their company.
When Congress passed the healthcare bill in March 2010, everyone said that there was an even greater need for whistleblowers to identify fraud in the healthcare industry. But with the passage of a few months now, it looks like these whistleblowers are getting a raw deal.
A blog post on www.quitamteam.com mentions a New England Journal of Medicine (NEJM) study entitled, "Whistle-blowers' experiences in fraud litigation against pharmaceutical companies." The study, it says, confirms what was already common knowledge: whistleblowers who report healthcare...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: